Sep 21, 2016
GynTect, a molecular diagnostic test developed by the biotech company oncgnostics, allows fast and reliable diagnostics of cervical cancer and the corresponding precancerous stages.
Jan 20, 2016
Greiner Bio-One starts international marketing of the cervical cancer triage test GynTect®
Nov 18, 2015
Jena / Frickenhausen (Germany), November 18th, 2015 – The oncgnostics GmbH has taken on board the international firm Greiner Bio-One GmbH as a sales and marketing partner for its new screening test for cervical cancer.